Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.

about

Barriers and facilitators to dispensing of intranasal naloxone by pharmacists.Geospatial Clustering of Opioid-Related Emergency Medical Services Runs for Public Deployment of Naloxone.Reviewing state-mandated training requirements for naloxone-dispensing pharmacists

P2860

Q50086968-DA3EA861-42A2-449B-9AB5-C5466D0C9AB1 Q55710796-1282D1C6-798F-4C63-8194-D4527A6D00FA Q57102751-7E7F3642-1542-40E0-801D-6772207B0267

P2860

Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.

Item

http://www.wikidata.org/entity/Q38978228

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.

@en

type

Item

label

Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.

@en

prefLabel

Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.

@en

P1476

Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.

@en

P2093

Elizabeth Lyvers

http://www.w3.org/2001/XMLSchema#string

J Douglas Thornton

http://www.w3.org/2001/XMLSchema#string

Nilanjana Dwibedi

http://www.w3.org/2001/XMLSchema#string

Virginia Ginger G Scott

http://www.w3.org/2001/XMLSchema#string

P2860

Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis

Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures.

CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence.

Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings.

Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania.

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.

The extended parallel process model: illuminating the gaps in research.

Current State of Opioid Therapy and Abuse.

Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain.

P304

S12-S18.e4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JAPH.2016.12.070

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28163027

http://www.w3.org/2001/XMLSchema#string

P932

5352525

http://www.w3.org/2001/XMLSchema#string

Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.

about

P2860

P2860

Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932